Showing 1 - 5 results of 5 for search 'Gianna Maria D’elia', query time: 0.03s Refine Results
  1. 1
    INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY

    INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY by Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni

    Published 2016-01-01
    Get full text
    Article
  2. 2
    Life-threatening autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura: successful seletive splenic artery embolization

    Life-threatening autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura: successful seletive splenic artery embolization by matteo molica, Fulvio Massaro, Giorgia Annechini, Erminia Baldacci, Gianna maria D'elia, Riccardo Rosati, Silvia maria trisolini, Paola Volpicelli, Robin Foà, Saveria Capria

    Published 2016-04-01
    Get full text
    Article
  3. 3
    High Basal Maximal Standardized Uptake Value (SUV<sub>max</sub>) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse

    High Basal Maximal Standardized Uptake Value (SUV<sub>max</sub>) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse by Giovanni Manfredi Assanto, Giulia Ciotti, Mattia Brescini, Maria Lucia De Luca, Giorgia Annechini, Gianna Maria D’Elia, Roberta Agrippino, Ilaria Del Giudice, Maurizio Martelli, Agostino Chiaravalloti, Alessandro Pulsoni

    Published 2021-06-01
    Get full text
    Article
  4. 4
    S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES

    S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES by Giovanni Manfredi Assanto, Martina Salvatori, Sara Pontecorvo, Gianluca Maiorana, Natalia Cenfra, Gianna Maria D’elia, Maria Paola Bianchi, Giorgia Annechini, Cristina Santoro Santoro, Maurizio Martelli, Agostino Tafuri, Alessandro Pulsoni, Ilaria Del Giudice, Antonio Chistolini

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

    Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi by Manuel Gotti, Roberta Sciarra, Alessandro Pulsoni, Francesco Merli, Stefano Luminari, Caterina Zerbi, Livio Trentin, Alessandro Re, Chiara Rusconi, Simonetta Viviani, Andrea Rossi, Federica Cocito, Barbara Botto, Erika Meli, Antonello Pinto, Irene Dogliotti, Guido Gini, Benedetta Puccini, Francesca Ricci, Luca Nassi, Alberto Fabbri, Anna Marina Liberati, Michele Merli, Andrea Riccardo Filippi, Maurizio Bonfichi, Valentina Zoboli, Germana Tartaglia, Giorgia Annechini, Gianna Maria D’Elia, Ilaria Del Giudice, Isabel Alvarez, Andrea Visentin, Stefano Pravato, Daniela Dalceggio, Chiara Pagani, Silvia Ferrari, Caterina Cristinelli, Tanja Lazic, Virginia Valeria Ferretti, Umberto Ricardi, Luca Arcaini

    Published 2023-04-01
    Get full text
    Article

Search Tools: